Efficacy of Cefepime Continuous Infusion Versus an Intermittent Dosing Regimen

PHASE4CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

September 30, 2006

Primary Completion Date

December 31, 2007

Study Completion Date

December 31, 2007

Conditions
SepsisBacteremia
Interventions
DRUG

cefepime

Administration of cefepime in continuous infusion (3 Gr over 24 hours) for 7-14 days at the discretion of the investigator. Administration of saline solution 0.9%, 50-100 mL over 30 minutes every 8 hours.

DRUG

cefepime

Administration of cefepime in intermittent infusion (1 Gr over 30 minutes every 8 hours) for 7-14 days at the discretion of the investigator.Administration of saline solution 0.9%, 50-250 mL over 24 hours

Trial Locations (7)

6

Clinica Palermo, Bogotá

Fundacion San Carlos, Bogotá

Hospital Santa Clara, Bogotá

Hospital Simon Bolivar, Bogotá

Hospital Universitario san Ignacio, Bogotá

Unknown

Hospital San Juan de Dios, Rionegro

Hospital San Jorge, Pareira

All Listed Sponsors
collaborator

Asociacion Colombiana de Infectologia, ACIN. Infectious Diseases Society of Colombia

UNKNOWN

collaborator

Hospital Simon Bolivar, Bogota

UNKNOWN

collaborator

Clinica Palermo, Bogota

UNKNOWN

collaborator

Hospital Santa Clara, Bogota

UNKNOWN

collaborator

Fundación San Carlos, Bogota

UNKNOWN

collaborator

Hospital san Juan de Dios, Antioquia

UNKNOWN

collaborator

Hospital san Jorge, Pereira

UNKNOWN

lead

Javeriana University

OTHER

NCT00609375 - Efficacy of Cefepime Continuous Infusion Versus an Intermittent Dosing Regimen | Biotech Hunter | Biotech Hunter